All terms

    AI Act Conformity Assessment (Medical Devices)

    For AI-enabled medical devices, AI Act requirements are assessed through the MDR/IVDR notified-body procedure, not a separate CE route.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed July 25, 2026

    Definition

    Article 43(3) provides that where an AI system is a safety component of, or is itself, a product covered by Annex I legislation such as the MDR or IVDR, the AI Act requirements are checked as part of the conformity assessment procedure under that legislation. The notified body performing the MDR/IVDR assessment therefore extends its scope to cover the relevant AI Act articles.
    What the regulation says
    Regulation (EU) 2024/1689 (AI Act), adopted on 13 June 2024, links certain high-risk AI assessments to existing product conformity assessment procedures. Under Article 6(1), this applies where AI is a safety component of, or itself constitutes, a product covered by Annex I legislation and that product requires third-party conformity assessment. Article 43(3) integrates the AI Act’s Chapter III, Section 2 requirements into that assessment. For MedTech, the relevant frameworks include Regulation (EU) 2017/745 (MDR), Article 52, applicable from 26 May 2021, and Regulation (EU) 2017/746 (IVDR), Article 48, applicable from 26 May 2022. Manufacturers must therefore address applicable AI requirements alongside device requirements, including risk management, data governance, technical documentation, record-keeping, transparency, human oversight, accuracy, robustness and cybersecurity under Articles 8 to 15. Article 43(3) allows notified bodies to assess these AI requirements only where their compliance with specified AI Act competence and organisational requirements has been assessed through the relevant designation procedure. An existing MDR or IVDR designation is therefore not automatically sufficient. Article 113 makes Article 6(1) and its corresponding obligations applicable from 2 August 2027.

    What this means in practice

    Practically, manufacturers must ensure their notified body is designated for the AI Act scope relevant to the device. Technical documentation under MDR Annex II or IVDR Annex II must be extended to include the AI Act Annex IV elements (data governance, training methodology, evaluation, cybersecurity, human oversight).

    Examples

    • An AI-powered diagnostic imaging system, classified as a Class IIb medical device under the MDR, will undergo a single conformity assessment procedure by its notified body, which will simultaneously verify compliance with both MDR and the relevant AI Act provisions.
    • A software as a medical device (SaMD) utilizing machine learning for predicting patient deterioration, already CE-marked under IVDR, will need its manufacturer to update technical documentation to demonstrate adherence to AI Act requirements for data quality and human oversight.
    • A manufacturer developing an AI-enabled surgical robot must ensure their notified body, designated for the device's MDR classification, is also accredited to evaluate the AI component's conformity with the comprehensive AI Act stipulations.
    Common pitfalls
    • •Selecting a notified body designated only under MDR without confirming AI Act scope designation.
    • •Duplicating documentation instead of integrating AI Act evidence into the existing technical file.

    Frequently asked questions

    No, Article 43(3) provides that where an AI system is a safety component of, or is itself, a product covered by Annex I legislation such as the MDR or IVDR, the AI Act requirements are checked as part of that product's existing conformity assessment procedure rather than through a separate AI Act certification process. There is a single CE mark and a single conformity assessment procedure, with the Notified Body's scope extended to cover the relevant AI Act articles alongside the device regulation requirements.
    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Latest in MedTech

    Sources

    3 sources

    Every citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

    Tier 1Binding law and standards· 1Tier 2Regulator guidance and consensus· 1Tier 4Trade press and expert commentary· 1
    Link health: 3 verified· last checked 2026-06-20
    EUR-Lex·1RAPS·1FDA·1
    1. 1
      Regulation (EU) 2024/1689, Article 43
      Tier 1 Verified
      EUR-Lexeur-lex.europa.eu
    2. 2
      RAPS Regulatory Focus
      Tier 4 Verified
      RAPSraps.org
    3. 3
      FDA - Medical Devices
      Tier 2 Verified
      FDAfda.gov

    Inline markers like [1] jump to the matching reference above.